Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.3900
-0.0050 (-1.27%)
Jan 30, 2026, 12:56 PM AEST
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 165.87 million as of January 29, 2026. Its market cap has increased by 277.82% in one year.
Market Cap
165.87M
Enterprise Value
152.86M
Revenue
5.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 165.87M, an increase of 231.73%. That is a compound annual growth rate of 4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 165.87M | 10.17% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Botanix Pharmaceuticals | 226.56M |
| Tetratherix | 194.43M |
| Recce Pharmaceuticals | 189.42M |
| Actinogen Medical | 153.20M |
| Paradigm Biopharmaceuticals | 138.72M |
| Proteomics International Laboratories | 118.87M |
| Island Pharmaceuticals | 113.00M |
| Imugene | 110.32M |